These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7450929)

  • 41. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):321-6. PubMed ID: 7106168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SULPHAPHENAZOLE-INDUCED HYPOGLYCAEMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS.
    CHRISTENSEN LK; HANSEN JM; KRISTENSEN M
    Lancet; 1963 Dec; 2(7321):1298-301. PubMed ID: 14071924
    [No Abstract]   [Full Text] [Related]  

  • 43. Paradoxical behaviour of phenylbutazone in African diabetics.
    Owusu SK; Ocran K
    Lancet; 1972 Feb; 1(7747):440-1. PubMed ID: 4110673
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of phenylbutazone on the metabolism of C14-cortisol.
    Downie WW; Reid G; Browning MC
    Ann Rheum Dis; 1973 Jan; 32(1):89-90. PubMed ID: 4685890
    [No Abstract]   [Full Text] [Related]  

  • 45. [Studies on the effect of uremia on phenylbutazone and aminophenazone metabolism in man].
    Leber HW; Harders A; Schütterle G
    Klin Wochenschr; 1972 Dec; 50(23):1092-6. PubMed ID: 4643487
    [No Abstract]   [Full Text] [Related]  

  • 46. A screening test for slow metabolisers of tolbutamide.
    Page MA; Boutagy JS; Shenfield GM
    Br J Clin Pharmacol; 1991 Jun; 31(6):649-54. PubMed ID: 1867959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: the role of genetic factors.
    Andreasen PB; Froland A; Skovsted L; Andersen SA; Hauge M
    Acta Med Scand; 1973 Jun; 193(6):561-4. PubMed ID: 4738705
    [No Abstract]   [Full Text] [Related]  

  • 48. The efficacy of oral tolbutamide in chronic alcoholics.
    Horowitz SH; Johnson BF
    Am J Med Sci; 1972 Nov; 264(5):395-400. PubMed ID: 4650130
    [No Abstract]   [Full Text] [Related]  

  • 49. Proceedings: Changes of pharmacokinetic parameters of new antiinflammatory drugs influenced by drug interaction.
    Zathurecký L; Szelepcsényiová A; Bruncková E; Masaryková V; Hajnovic F
    Acta Pharm Suec; 1974 Dec; 11(6):654-5. PubMed ID: 1173537
    [No Abstract]   [Full Text] [Related]  

  • 50. [The tissue cage in dogs--a pharmacologic model for the representation of plasma and tissue kinetics].
    Scherkl R; Hashem A; Frey HH
    Dtsch Tierarztl Wochenschr; 1996 May; 103(5):174-7. PubMed ID: 8964239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inactivation of alpha1-antiproteinase induced by phenylbutazone: participation of peroxyl radicals and hydroperoxide.
    Muraoka S; Miura T
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):261-6. PubMed ID: 16930300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
    Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I
    Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of lead exposure on plasma phenylbutazone levels in rats.
    Basu N; Kulsreshtha T
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):61-2. PubMed ID: 8132249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Griseofulvin-tolbutamide interaction.
    Iyer KS; Ummer A; Menon PN; Verghese Z
    Indian J Physiol Pharmacol; 1970 Oct; 14(4):293-6. PubMed ID: 5526136
    [No Abstract]   [Full Text] [Related]  

  • 55. [On the problem of the effect of phenylbutazone on the function of the adrenal cortex and on the biological half-life of cortisol].
    SCHWARZ K
    Klin Wochenschr; 1960 Mar; 38():227-30. PubMed ID: 14444072
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetic control of phenylbutazone metabolism in man.
    Whittaker JA; Evans DA
    Br Med J; 1970 Nov; 4(5731):323-8. PubMed ID: 5528753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug metabolism in a geriatric population.
    O'Malley K; Stevenson IH; Crooks J
    Clin Sci; 1971 Aug; 41(2):6P. PubMed ID: 5564320
    [No Abstract]   [Full Text] [Related]  

  • 58. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
    Palamanda J; Feng WW; Lin CC; Nomeir AA
    Drug Metab Dispos; 2000 Jan; 28(1):38-43. PubMed ID: 10611138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistence of phenylbutazone in horses producing acid urines.
    Moss MS; Haywood PE
    Vet Rec; 1973 Aug; 93(5):124-5. PubMed ID: 4763773
    [No Abstract]   [Full Text] [Related]  

  • 60. [Medicamentous enzyme induction and hormonal contraception. Second communication: effects of phenobarbital and phenylbutazone on hormonal contraception (author's transl)].
    Böhm S
    Zentralbl Gynakol; 1980; 102(17):966-73. PubMed ID: 7467939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.